The Etobicoke General Hospital is a community hospital located at 101 Humber College Boulevard in the Etobicoke district of Toronto, Ontario, Canada. Etobicoke General Hospital serves the communities of Etobicoke, Brampton, Mississauga, Caledon, and Woodbridge.

There are 262 beds in Etobicoke General Hospital.

During the past decade, Etobicoke General Hospital conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Etobicoke General Hospital" #1 sponsor was "University Health Network, Toronto" with 3 trials, followed by "Bayer" with 1 trials sponsored, "McMaster University" with 1 trials sponsored, "Sunnybrook Health Sciences Centre" with 1 trials sponsored and "The Hospital for Sick Children" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Etobicoke General Hospital" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Apotex Inc." with 1 trials as a collaborator, "Arch Biopartners Inc." with 1 trials as a collaborator and "Canadian Frailty Network" with 1 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Etobicoke General Hospital" are "COVID-19" (2 trials), "ARDS" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Covid-19" (1 trials) and "Covid19" (1 trials). Many other conditions were trialed in "Etobicoke General Hospital" in a lesser frequency.

Most popular intervention types in "Etobicoke General Hospital" are "Other" (3 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Accelerated medical clearance and surgery" (1 trials), "Artesunate" (1 trials), "BAY2976217" (1 trials), "BUN adjustable fortification" (1 trials) and "Decidual Stromal Cells (DSC)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Etobicoke General Hospital" are 8 trials for "All" genders.

Currently, there are NaN active trials in "Etobicoke General Hospital". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Etobicoke General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Etobicoke General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".